Tag Archives: Compound Drug Recall

Featured Stories

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Senators promise action to prevent the next fungal meningitis outbreak

Lawmakers on Capitol Hill have promised to update federal regulations, namely with the Food and Drug Administration, that would bring pharmaceutical drug compounding labs under the agency’s eye in the future in hopes of avoiding situations like the current deadly … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls | Tagged , , |

Skepticism of company at center of fungal meningitis outbreak continues to grow

The company at the center of the deadly fungal meningitis outbreak has been under increased oversight since a 2006 inspection of its pharmacy labs discovered widespread deficiencies in protocols for manufacturing drugs. According to an AP report, New England Compounding … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , |

Meningitis outbreak toll now at 205 sick, 14 dead

Federal health officials have drastically increased the amount of confirmed cases of fungal meningitis linked to the use of a contaminated vial of an epidural steroid drug injection. According to Reuters, the Centers for Disease Control and Prevention this weekend … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , |

Another death, more infections reported in fungal meningitis outbreak

Health officials are reporting another death, the twelfth, and more illnesses in the outbreak of fungal meningitis linked to a contaminated epidural steroid injection. According to a recent update from MedPageToday.com and other sources, the Centers for Disease Control and … Continue reading

Posted in Pharmaceuticals | Tagged , |

State regulator, pharmaceutical executive cloud picture on fungal meningitis outbreak

A sitting member of Massachusetts’ regulatory agency that oversees pharmaceutical safety has a direct link to the company implicated in the nationwide outbreak of fungal meningitis. According to a Boston Globe report this week, Sophia Pasedis has recused herself from … Continue reading

Posted in Pharmaceuticals | Tagged , , |

Franck’s Pharmacy Expands Recall Of Compounded Drugs

Franck’s Pharmacy just expanded its recall of compounded drugs, the U.S. Food & Drug Administration (FDA) just announced. Compounding involves mixing drugs using bulk ingredients, typically when patients are allergic to inactive ingredients in medicines approved by the FDA or … Continue reading

Posted in Pharmaceuticals | Tagged |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.